PolyPid Ltd. Share Price & Technical Analysis
PYPD · $4.84 (-3.59%)
Healthcare / Biotechnology
$4.84
-3.59%
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
11% return in May, -7% avg return in past 3 year May month.
17% return in 2026, -55% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 5% | -9% | 7% | 2% | 11% | – | – | – | – | – | – | – | 17% |
| 25 | -9% | 14% | -18% | 4% | -3% | 17% | -3% | -3% | -3% | 15% | 5% | 8% | 23% |
| 24 | 54% | -16% | -18% | -2% | -12% | -4% | -20% | 0% | -3% | -9% | -3% | -9% | -42% |
| 23 | 0% | -12% | -31% | -9% | -7% | -7% | -5% | -17% | -50% | -9% | 15% | -14% | -146% |
| 22 | -23% | -9% | 33% | -14% | 10% | -15% | 11% | 19% | -80% | -21% | -15% | -13% | -116% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Uptrend
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$84.00M
P/E ratio
—
52W high
$5.20
52W low
$2.44
Volume
1,48,892
Beta
1.41
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is PolyPid Ltd. share price today?
- PolyPid Ltd. (PYPD) last traded around $4.84 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PYPD have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PYPD. Download the app for real-time alerts.
- How can I analyze PolyPid Ltd. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.